デフォルト表紙
市場調査レポート
商品コード
1672124

バイオバンキングの世界市場調査レポート:産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global Biobanking Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033


出版日
ページ情報
英文 148 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
バイオバンキングの世界市場調査レポート:産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 148 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオバンキングの世界市場規模は、2024年の38億4,000万米ドルから2033年には107億3,000万米ドルに成長し、2026年から2033年の予測期間中に12.07%の堅調な年間平均成長率(CAGR)を示すと予測されます。

バイオバンク市場は、研究や臨床応用のための生物学的サンプルやデータに対する需要の増加を背景に、大きく成長する見通しです。バイオバンクは、血液、組織、DNAサンプルを含む広範な生物試料へのアクセスを提供することで、生物医学研究を支援する上で重要な役割を果たしています。個別化医療とゲノミクスへの世界の注目が高まるにつれて、バイオバンク・サービスへの需要が高まり、この市場は堅調な拡大が見込まれます。

さらに、バイオバンキング技術の進歩が市場内の技術革新を促進しています。自動化されたサンプル処理、保管ソリューション、データ管理システムの開発は、バイオバンクの効率性と信頼性を高めています。これらの技術革新は、サンプルの完全性とアクセシビリティを向上させるだけでなく、ハイスループットシーケンスやバイオインフォマティクスなどの高度な調査手法とバイオバンクの統合を促進します。研究がバイオバンキングの新たな用途を模索し続ける中、研究成果の向上や共同研究の促進が期待されることから、市場はさらに拡大する可能性が高いです。

さらに、倫理的配慮と規制遵守が重視されるようになり、バイオバンクの状況が形成されつつあります。バイオバンクがサンプルの収集と使用に関する複雑な倫理的枠組みや規制を乗り越えるにつれ、透明性が高くコンプライアンスに準拠したバイオバンキングの実践に対する需要が高まる可能性が高いです。この動向は、信頼と透明性の維持が不可欠な、患者の同意とデータ・プライバシーの文脈に特に関連しています。バイオバンキング市場が進化を続ける中、技術の進歩、倫理的配慮、協力関係の重視の組み合わせが、将来の軌道を形成する上で重要な役割を果たすでしょう。

当社のレポートは、様々な業界や市場に関する包括的かつ実用的な洞察をお客様に提供するために、細心の注意を払って作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます:

市場概要:市場概要:定義、分類、業界の現状など、市場に関する詳細なイントロダクション

市場促進要因:市場成長に影響を与える主な促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析:製品タイプ、用途、最終用途、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢:市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場プレイヤーの包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測:過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析:地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会:現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 バイオバンキング産業分析

  • イントロダクション-市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 バイオバンキングの世界市場分析:製品・サービス別

  • 製品・サービス別、概要
  • 製品・サービス別、過去および予測データ分析
  • 機器(保管機器、サンプル分析機器、サンプル処理機器、サンプル輸送機器)
  • 消耗品(保管用消耗品、分析用消耗品、処理用消耗品、採取用消耗品)
  • サービス別
  • ソフトウェア

第6章 バイオバンキングの世界市場分析:サンプルタイプ別

  • サンプルタイプ別、概要
  • サンプルタイプ別、過去および予測データ分析
  • 血液製品
  • ヒト組織
  • 細胞ライン
  • 核酸
  • 生物学的液体
  • ヒト廃棄物

第7章 バイオバンキングの世界市場分析:保管タイプ別

  • ストレージタイプ別、概要
  • 保管タイプ別、過去および予測データ分析
  • 手動
  • 自動

第8章 バイオバンキングの世界市場分析:所有者別

  • 所有者別、概要
  • 所有者別、過去および予測データ分析
  • 国家/地域機関
  • 非営利団体
  • 民間機関

第9章 バイオバンキングの世界市場分析:用途別

  • 用途別、概要
  • 用途別、過去および予測データ分析
  • 再生医療
  • ライフサイエンス調査
  • 臨床研究

第10章 バイオバンキングの世界市場分析:最終用途別

  • 最終用途別、概要、
  • 最終用途別、過去および予測データ分析
  • 製薬・バイオテクノロジー企業およびCRO
  • 学術・研究機関
  • 病院

第11章 バイオバンキングの世界市場分析:地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米:セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州:セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績と予測
    • アジア太平洋地域:セグメント別
    • アジア太平洋地域国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ:セグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ:セグメント別
    • 中東・アフリカ国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第12章 バイオバンキング企業の競合情勢

  • バイオバンキング市場競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品の発売
  • その他の開発

第13章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Becton
  • Dickinson And Company
  • PHC Holdings Corporation
  • Avantor Inc.
  • Greiner Holding AG
  • Azenta Inc.
  • Tecan Trading AG
  • Hamilton Company
  • Cryoport Inc.
  • Micronic
  • AMSBIO
  • Bay Biosciences LLC
  • BioKryo
  • SPT Labtech
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product &Service (USD MN)
  • Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment) Market Sales By Geography (USD MN)
  • Consumables (Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables) Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Analysis By Sample Type (USD MN)
  • Blood Products Market Sales By Geography (USD MN)
  • Human Tissues Market Sales By Geography (USD MN)
  • Cell Lines Market Sales By Geography (USD MN)
  • Nucleic Acids Market Sales By Geography (USD MN)
  • Biological Fluids Market Sales By Geography (USD MN)
  • Human Waste Products Market Sales By Geography (USD MN)
  • Analysis By Storage Type (USD MN)
  • Manual Storage Market Sales By Geography (USD MN)
  • Automated Storage Market Sales By Geography (USD MN)
  • Analysis By Ownership (USD MN)
  • Universities Market Sales By Geography (USD MN)
  • National/Regional Agencies Market Sales By Geography (USD MN)
  • Non-Profit Organizations Market Sales By Geography (USD MN)
  • Private Organizations Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Regenerative Medicine Market Sales By Geography (USD MN)
  • Life Science Research Market Sales By Geography (USD MN)
  • Clinical Research Market Sales By Geography (USD MN)
  • Analysis By End user (USD MN)
  • Pharmaceutical & Biotechnology Companies and CROs Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Global Biobanking Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Biobanking Report
  • Market Research Process
  • Market Research Methodology
  • Global Biobanking Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product &Service
  • Market Attractiveness Analysis By Sample Type
  • Market Attractiveness Analysis By Storage Type
  • Market Attractiveness Analysis By Ownership
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End user
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product &Service (USD MN)
  • Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment) Market Sales By Geography (USD MN)
  • Consumables (Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables) Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Global Market Analysis By Sample Type (USD MN)
  • Blood Products Market Sales By Geography (USD MN)
  • Human Tissues Market Sales By Geography (USD MN)
  • Cell Lines Market Sales By Geography (USD MN)
  • Nucleic Acids Market Sales By Geography (USD MN)
  • Biological Fluids Market Sales By Geography (USD MN)
  • Human Waste Products Market Sales By Geography (USD MN)
  • Global Market Analysis By Storage Type (USD MN)
  • Manual Storage Market Sales By Geography (USD MN)
  • Automated Storage Market Sales By Geography (USD MN)
  • Global Market Analysis By Ownership (USD MN)
  • Universities Market Sales By Geography (USD MN)
  • National/Regional Agencies Market Sales By Geography (USD MN)
  • Non-Profit Organizations Market Sales By Geography (USD MN)
  • Private Organizations Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Regenerative Medicine Market Sales By Geography (USD MN)
  • Life Science Research Market Sales By Geography (USD MN)
  • Clinical Research Market Sales By Geography (USD MN)
  • Global Market Analysis By End user (USD MN)
  • Pharmaceutical & Biotechnology Companies and CROs Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11212372

Global Biobanking Market size is anticipated to grow from USD 3.84 Billion in 2024 to USD 10.73 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 12.07% during the forecast period of 2026 to 2033.

The biobanking market is poised for significant growth, driven by the increasing demand for biological samples and data for research and clinical applications. Biobanks play a crucial role in supporting biomedical research by providing access to a wide range of biological materials, including blood, tissue, and DNA samples. As the global focus on personalized medicine and genomics intensifies, the demand for biobanking services is expected to rise, positioning this market for robust expansion.

Moreover, advancements in biobanking technologies are driving innovation within the market. The development of automated sample processing, storage solutions, and data management systems is enhancing the efficiency and reliability of biobanks. These innovations not only improve sample integrity and accessibility but also facilitate the integration of biobanking with advanced research methodologies, such as high-throughput sequencing and bioinformatics. As research continues to explore new applications for biobanking, the market is likely to expand further, driven by the promise of improved research outcomes and collaboration.

Additionally, the growing emphasis on ethical considerations and regulatory compliance is shaping the biobanking landscape. As biobanks navigate complex ethical frameworks and regulations regarding sample collection and usage, the demand for transparent and compliant biobanking practices is likely to increase. This trend is particularly relevant in the context of patient consent and data privacy, where maintaining trust and transparency is essential. As the biobanking market continues to evolve, the combination of technological advancements, ethical considerations, and a focus on collaboration will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product &Service

  • Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment)
  • Consumables (Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables)
  • Services
  • Software

By Sample Type

  • Blood Products
  • Human Tissues
  • Cell Lines
  • Nucleic Acids
  • Biological Fluids
  • Human Waste Products

By Storage Type

  • Manual Storage
  • Automated Storage

By Ownership

  • Universities
  • National/Regional Agencies
  • Non-Profit Organizations
  • Private Organizations

By Application

  • Regenerative Medicine
  • Life Science Research
  • Clinical Research

By End user

  • Pharmaceutical & Biotechnology Companies and CROs
  • Academic & Research Institutes
  • Hospitals
  • COMPANIES PROFILED
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Becton
  • Dickinson and Company
  • PHC Holdings Corporation
  • Avantor Inc.
  • Greiner Holding AG
  • Azenta Inc.
  • Tecan Trading AG
  • Hamilton Company
  • Cryoport Inc.
  • Micronic
  • AMSBIO
  • Bay Biosciences LLC
  • BioKryo
  • SPT Labtech
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. BIOBANKING INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product &Service
    • 3.7.2 Market Attractiveness Analysis By Sample Type
    • 3.7.3 Market Attractiveness Analysis By Storage Type
    • 3.7.4 Market Attractiveness Analysis By Ownership
    • 3.7.5 Market Attractiveness Analysis By Application
    • 3.7.6 Market Attractiveness Analysis By End user
    • 3.7.7 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIOBANKING MARKET ANALYSIS BY PRODUCT &SERVICE

  • 5.1. Overview By Product &Service
  • 5.2. Historical and Forecast Data Analysis By Product &Service
  • 5.3. Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment) Historic and Forecast Sales By Regions
  • 5.4. Consumables (Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables) Historic and Forecast Sales By Regions
  • 5.5. Services Historic and Forecast Sales By Regions
  • 5.6. Software Historic and Forecast Sales By Regions

6. GLOBAL BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE

  • 6.1. Overview By Sample Type
  • 6.2. Historical and Forecast Data Analysis By Sample Type
  • 6.3. Blood Products Historic and Forecast Sales By Regions
  • 6.4. Human Tissues Historic and Forecast Sales By Regions
  • 6.5. Cell Lines Historic and Forecast Sales By Regions
  • 6.6. Nucleic Acids Historic and Forecast Sales By Regions
  • 6.7. Biological Fluids Historic and Forecast Sales By Regions
  • 6.8. Human Waste Products Historic and Forecast Sales By Regions

7. GLOBAL BIOBANKING MARKET ANALYSIS BY STORAGE TYPE

  • 7.1. Overview By Storage Type
  • 7.2. Historical and Forecast Data Analysis By Storage Type
  • 7.3. Manual Storage Historic and Forecast Sales By Regions
  • 7.4. Automated Storage Historic and Forecast Sales By Regions

8. GLOBAL BIOBANKING MARKET ANALYSIS BY OWNERSHIP

  • 8.1. Overview By Ownership
  • 8.2. Historical and Forecast Data Analysis By Ownership
  • 8.3. Universities Historic and Forecast Sales By Regions
  • 8.4. National/Regional Agencies Historic and Forecast Sales By Regions
  • 8.5. Non-Profit Organizations Historic and Forecast Sales By Regions
  • 8.6. Private Organizations Historic and Forecast Sales By Regions

9. GLOBAL BIOBANKING MARKET ANALYSIS BY APPLICATION

  • 9.1. Overview By Application
  • 9.2. Historical and Forecast Data Analysis By Application
  • 9.3. Regenerative Medicine Historic and Forecast Sales By Regions
  • 9.4. Life Science Research Historic and Forecast Sales By Regions
  • 9.5. Clinical Research Historic and Forecast Sales By Regions

10. GLOBAL BIOBANKING MARKET ANALYSIS BY END USER

  • 10.1. Overview By End user
  • 10.2. Historical and Forecast Data Analysis By End user
  • 10.3. Pharmaceutical & Biotechnology Companies and CROs Historic and Forecast Sales By Regions
  • 10.4. Academic & Research Institutes Historic and Forecast Sales By Regions
  • 10.5. Hospitals Historic and Forecast Sales By Regions

11. GLOBAL BIOBANKING MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Regional Outlook
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.3.2 North America By Segment Sales Analysis
    • 11.3.3 North America By Country Sales Analysis
    • 11.3.4 United States Sales Analysis
    • 11.3.5 Canada Sales Analysis
    • 11.3.6 Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.4.2 Europe By Segment Sales Analysis
    • 11.4.3 Europe By Country Sales Analysis
    • 11.4.4 United Kingdom Sales Analysis
    • 11.4.5 France Sales Analysis
    • 11.4.6 Germany Sales Analysis
    • 11.4.7 Italy Sales Analysis
    • 11.4.8 Russia Sales Analysis
    • 11.4.9 Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.5.2 Asia Pacific By Segment Sales Analysis
    • 11.5.3 Asia Pacific By Country Sales Analysis
    • 11.5.4 China Sales Analysis
    • 11.5.5 India Sales Analysis
    • 11.5.6 Japan Sales Analysis
    • 11.5.7 South Korea Sales Analysis
    • 11.5.8 Australia Sales Analysis
    • 11.5.9 South East Asia Sales Analysis
    • 11.5.10 Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.6.2 Latin America By Segment Sales Analysis
    • 11.6.3 Latin America By Country Sales Analysis
    • 11.6.4 Brazil Sales Analysis
    • 11.6.5 Argentina Sales Analysis
    • 11.6.6 Peru Sales Analysis
    • 11.6.7 Chile Sales Analysis
    • 11.6.8 Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.7.2 Middle East & Africa By Segment Sales Analysis
    • 11.7.3 Middle East & Africa By Country Sales Analysis
    • 11.7.4 Saudi Arabia Sales Analysis
    • 11.7.5 UAE Sales Analysis
    • 11.7.6 Israel Sales Analysis
    • 11.7.7 South Africa Sales Analysis
    • 11.7.8 Rest Of Middle East And Africa Sales Analysis

12. COMPETITIVE LANDSCAPE OF THE BIOBANKING COMPANIES

  • 12.1. Biobanking Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13. COMPANY PROFILES OF BIOBANKING INDUSTRY

  • 13.1. Top Companies Market Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. Merck KGaA
    • 13.3.1 Company Overview
    • 13.3.2 Company Revenue
    • 13.3.3 Products
    • 13.3.4 Recent Developments
  • 13.4. Thermo Fisher Scientific Inc.
    • 13.4.1 Company Overview
    • 13.4.2 Company Revenue
    • 13.4.3 Products
    • 13.4.4 Recent Developments
  • 13.5. Becton
    • 13.5.1 Company Overview
    • 13.5.2 Company Revenue
    • 13.5.3 Products
    • 13.5.4 Recent Developments
  • 13.6. Dickinson And Company
    • 13.6.1 Company Overview
    • 13.6.2 Company Revenue
    • 13.6.3 Products
    • 13.6.4 Recent Developments
  • 13.7. PHC Holdings Corporation
    • 13.7.1 Company Overview
    • 13.7.2 Company Revenue
    • 13.7.3 Products
    • 13.7.4 Recent Developments
  • 13.8. Avantor Inc.
    • 13.8.1 Company Overview
    • 13.8.2 Company Revenue
    • 13.8.3 Products
    • 13.8.4 Recent Developments
  • 13.9. Greiner Holding AG
    • 13.9.1 Company Overview
    • 13.9.2 Company Revenue
    • 13.9.3 Products
    • 13.9.4 Recent Developments
  • 13.10. Azenta Inc.
    • 13.10.1 Company Overview
    • 13.10.2 Company Revenue
    • 13.10.3 Products
    • 13.10.4 Recent Developments
  • 13.11. Tecan Trading AG
    • 13.11.1 Company Overview
    • 13.11.2 Company Revenue
    • 13.11.3 Products
    • 13.11.4 Recent Developments
  • 13.12. Hamilton Company
    • 13.12.1 Company Overview
    • 13.12.2 Company Revenue
    • 13.12.3 Products
    • 13.12.4 Recent Developments
  • 13.13. Cryoport Inc.
    • 13.13.1 Company Overview
    • 13.13.2 Company Revenue
    • 13.13.3 Products
    • 13.13.4 Recent Developments
  • 13.14. Micronic
    • 13.14.1 Company Overview
    • 13.14.2 Company Revenue
    • 13.14.3 Products
    • 13.14.4 Recent Developments
  • 13.15. AMSBIO
    • 13.15.1 Company Overview
    • 13.15.2 Company Revenue
    • 13.15.3 Products
    • 13.15.4 Recent Developments
  • 13.16. Bay Biosciences LLC
    • 13.16.1 Company Overview
    • 13.16.2 Company Revenue
    • 13.16.3 Products
    • 13.16.4 Recent Developments
  • 13.17. BioKryo
    • 13.17.1 Company Overview
    • 13.17.2 Company Revenue
    • 13.17.3 Products
    • 13.17.4 Recent Developments
  • 13.18. SPT Labtech
    • 13.18.1 Company Overview
    • 13.18.2 Company Revenue
    • 13.18.3 Products
    • 13.18.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies